MEDIFAST INC (MED) insider trading
MEDIFAST INC insiders have made 1 open-market purchase worth $68k since Oct 30, 2026, by 1 insider. The latest: Parsa Kiai (Director) bought $68k, filed Oct 30, 2026, scored 40 out of 100.
Follow MED, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
Parsa KiaiDirectorDirector | +37% stake | 40 | $68k 5,557 at $12.24 |
waiting | waiting |
Insider sales
1 open-market sale on record
| Filed | Insider | Sold |
|---|---|---|
| Oct 1 Form 4 (opens sec.gov) |
Daniel R. ChardDirector · planned (10b5-1) | $226k 19,089 at $11.85 · 5% of holdings |
Most insider sales are planned in advance or made for personal reasons, so a sale says less than a buy.
Insiders who bought MED
- Parsa Kiai Director
Questions
Are insiders buying MED stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $68k, against $226k of open-market sales.
Who bought MED stock most recently?
Parsa Kiai, Director, bought 5,557 shares for $68k (Form 4 (opens sec.gov), filed Oct 30, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
- MKC $45k
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer